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20—50 years) were enrolled in this study. All of the injec-
tion drug users were prisoners. Hepatitis B surface antigen
(HBsAg), hepatitis B surface antibody (anti-HBs), anti-HBc,
Anti-HIV and hepatitis C antibody (anti-HCV) were tested in
all subjects.
Results: Of the 531 blood donors, 11 subjects (2.1%) had
isolated anti-HBc and of 153 injection drug users, 12 cases
(7.84%) showed isolated anti-HBc. All of 12 injection drug
users with isolated anti-HBc were also HCV positive. Sero-
logic proﬁle of 2 groups was shown in Table 1.
Variable Blood donors Injection drug users P value
HBsAg 0.4% 7.2% 0
Anti-HBs 31.8% 43.8% 0
Anti-HBc 11.5% 35% 0
Anti-HCV 0.2% 59.5% 0
Anti-HIV 0% 5.9% 0
Conclusion: Our study showed that prevalence of isolated
anti-HBc among injection drug users was 3.73 fold in com-
parison with blood donors. This study supports that injection
drug use and incarceration is contributing to increase preva-
lence of isolated anti-HBc.
doi:10.1016/j.ijid.2010.02.1992
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Persistence of protective antibodies against Hepatitis B
virus among vaccinated health workers, Al-Hussein Hos-
pital, Salt, Jordan, 2008
S. Sheikh Ali 1,∗, M. Jaghbir2
1 MOH, Amman, Jordan
2 Dean Faculty of Medicine, Hashemite University, Zarka Jor-
dan, Amman, Jordan
Background: Health workers (HWs) have occupational
exposure to blood or body ﬂuids; unvaccinated HWs or those
vaccinated with low hepatitis-B surface antibodies‘‘(anti-
HBs) <10UI’’ are at higher risk of Hepatitis-B infection they
could be focus for dissemination of infection. Duration of
protection after fully vaccination is not known. The objec-
tive is to assess the immunogenicity ‘‘anti-HBs ‘‘10mIU/ml’’
post vaccination among HWs.
Methods: Two stage study; cross-sectional and follow-up
prospective-cohort. Voluntary HWs who met the inclusion
criteria were surveyed and tested primary for hepatitis-B
core antibodies and hepatitis-B surface antigen, only those
with negative results were tested for ‘‘anti-HBs’’; fully vac-
cinated HWs with negative anti-HBs were voluntary enrolled
in the second stage,retested for anti-HBs after 45 days from
a booster dose.
Results: 252 HWs participate in the study; 10% of those
don’t meet the inclusion criteria, primary study sample was
226 HWs, 81% were fully and 19% were partially vaccinated.
There was a signiﬁcant association between the number of
vaccine doses and the presence of anti-HBs, p-value-0.0002.
There is a signiﬁcant difference regarding the presence of
anti-HBs among fully or partially vaccinated HWs; P-value-
0.003. To verify ‘‘persistence’’, statistics were limited to
182 fully vaccinated HWs; was found signiﬁcant associa-
tion between the time period from the last administrated
doses, age at vaccination, duration of practice and the per-
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istence of antibodies, P-value-0.00004, 0.040, and 0.010
espectively. There were no signiﬁcant differences regard-
ng the vaccination site, Fisher exact: 0.7018. There is no
ssociation between the ‘‘place of working, profession, and
requency of exposure to blood or needle stick injury’’ and
he persistence of antibodies. 8% of participants in second
tage didn’t response by reforming the anti-HBs. 65% of
Ws who were exposed to a needle stick injury report no
ost exposure preventive measures was taken after they had
eported the injury.
Conclusion: The Hepatitis-B prevalence among HWs was
0%; the non-response rate to vaccine was 8%; the prob-
bility for antibodies-persistence is declining by time;
robability of antibodies persistence is highly signiﬁcant if
he period from the last administrated dose is less than three
ears and increases with a booster dose. The older age the
accine was administrated the higher was the risk to non
esponse to vaccine.
oi:10.1016/j.ijid.2010.02.1993
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egional and ethnical aspects of viral hepatitis B in preg-
ant women in Slovakia
. Kristian, I. Schreter, Z. Paralicova, P. Jarcuska ∗, L.
iegfried, S. Porubcin
Faculty of Medicine, University of P.J.Safarik, Kosice, Slo-
akia
Background: The estimated prevalence of HBsAg in Slo-
ak population is <2% with supposed regional differences
nd higher prevalence of HBV infection in Roma popula-
ion. Pregnant women constitute a special subgroup, that
s subject to routine HBsAg screening because of the risk
f vertical transmission, and also pregnancy can modify the
ourse of hepatitis B infection. The aim of this study was
o determine the prevalence of HBV infection in pregnant
omen in districts of eastern Slovakia with diverse preva-
ence of Roma population and to determine the subset of
omen with chronic hepatitis B and increased risk of vertical
ransmission.
Methods: We have analyzed data from 9 regional Depart-
ents of Clinical Microbiology from January 2008 till June
009. We have evaluated the portion of HBsAg positive ﬁnd-
ngs from the overall examined samples and among pregnant
omen. Available sera from HBsAg positive pregnant women
ere also screened for ALT, HBeAg and HBV DNA.
Results: Overall, 44,912 sera samples were examined,
ith 10,739 from pregnancy screening. The number of HBsAg
ositive samples overall and during pregnancy was 803
1.79%) and 251 (2.34%) respectively. Comparing districts
ith higher (>4%) and lower (<3%) prevalence of Roma popu-
ation, there was no notable difference in the overall HBsAg
revalence (1.85% vs. 1.68%), however in the subgroup of
regnant women (2.69% vs. 1.25%) this difference was highly
igniﬁcant (p < 0.001). HBV DNA was evaluated in 158 preg-
ant women, 19 patients had viral load >105 copies/ml, 27
n the range of 104-105 copies/ml and 112 patients < 104
r negative. HBeAg positivity was conﬁrmed in 17 of 146
xamined samples (11.6%) and elevated ALT in 11 of 69 cases
15.9%). Twelve out of 58 patients with normal ALT (21%) had
e th In
v
H
w
S
t
i
c
w
t
i
s
d
5
N
t
c
B
E
1
T
2
n
d
G
5
D
2
m
1
R
a
e
a
v
o
o
k
9
R
H HCV Core Ag
Positive Patients Negative Patiens
0 0 4
1 0 2
2 2 0
1 12 1
1 102 0
T 116 7
p
f
w
ﬁ
h
r
b
d
5
N
i
G
R
t
o
i
a
o
H
e
P
o
a
e
t
p
b
O
p
w
a
a
a
p
l
showed that the prevalence of HCV infection in Kerman is
more than other provinces of Iran.
Conclusion: In contrast with other studies HBV-DNA in
these patients could not be detected, hence, it seems that228 14
iral load >104 copies/ml, 3 of them were simultaneously
BeAg positive.
Conclusion: The prevalence of HBV infection in pregnant
omen in eastern Slovakia exceeds the overall estimated
lovak prevalence, and in districts with higher Roma popula-
ion conﬁrms presumed higher prevalence of HBV infection
n this population. Majority of infected women are HBsAg
arriers, but we have conﬁrmed several cases of pregnant
omen with high viral load and increased risk of vertical
ransmission. We consider evaluation of ALT in pregnancy as
nsufﬁcient for ruling out chronic hepatitis B. This study was
upported by VEGA grant No.1/0050/08.
oi:10.1016/j.ijid.2010.02.1994
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ew approaches in in-vitro diagnosis of Hepatitis C infec-
ions: The diagnostic performance of new hepatitis C virus
ore antigen detection test
. Kocazeybek1, P. Yuksel1,∗, S. Saribas1, R. Caliskan1, S.
rgin1, M. Aslan1, A. Yalcıner2, M.M. Torun1
Istanbul University Cerrahpasa Faculty of Medicine,
urkey, Turkey
Duzen Laboratory, Istanbul, Turkey
Background: There are problems currently in the diag-
osis of hepatitis C infections We aimed to investigate the
iagnostic performance of new HCV Ag (Abbott Diagnostic,
ermany.
Methods: All of the study cases were applied to the
stanbul University Microbiology and Clinical Microbiology
epartment and to the Düzen laboratory between February
008-March 2009. Molecular (real-time PCR) and serological
ethods (Micro-ELISA) were applied to the all of the cases,
23 HCV RNA-positive and anti-HCV positive cases, 48 HCV
NA negative and anti-HCV negative cases were included
s the study and negative control groups, respectively. We
valuated sensitivity, speciﬁcity, positive predictive (PPV)
nd negative predictive (NPV) values, accuracy and kappa
alues of antigen detection HCV Ag kit which includes mon-
clonal anti-HCV antibodies against HCV core antigen coated
n the solid phase.
Results: Sensitivity, speciﬁcity, PPV, NPV, accuracy and
appa values were evaluated as 94.3%, 97.9%, 99.1%, 87%,
5.3% and 88%, respectively for HCV Ag kit.
Viral load distrubition and HCV Core Ag results of HCV
NA Positive Patients
CV RNA (IU/ml) HCV RNA Positive Patients
—1000 4
001—2000 2
001—10000 2
0001—100000 13
00001 and upper 102
otal 123Conclusion: As a result, the diagnostic performance
arameters of recently developed HCVAg kit have not satis-
actory results because false negative ratio was 5% and NPV
as 87%. We suggest that this situation is related with unsuf-ternational Congress on Infectious Diseases (ICID) Abstracts
cient analytic sensitivity especially for HCV cases which
ave a 2000 IU/ml and below viral load. We suggest that the
e-evaluation of the sensitivity of this kit will be usefull for
lood screening.
oi:10.1016/j.ijid.2010.02.1995
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o detected hepatitis B virus-DNA in thalassemic patients
nfected by hepatitis C virus in Kerman province of Iran
. Hassanshahiraviz
Faculty of medicine, rafsanjan, kerman, Iran, (Islamic
epublic of)
Background: Occult hepatitis B infection (OBI) is charac-
erized as a form of hepatitis in which despite of absence
f detectable hepatitis B surface antigen (HBsAg), HBV-DNA
s present in patient’s peripheral blood. This project was
imed to investigate the prevalence and clinical impact of
ccult HBV infection in thalassemic patients with chronic
CV infection.
Methods: In this cross-sectional study we have totally
xamined 60 patients suffering HBV and HCV infections by
CR and RT-PCR methods, respectively, in Kerman province
f Iran. ELISA technique (RADIM, Italy) was used to detect
nti-HBc, anti-HBs and HBsAg. The serum level of liver
nzymes (SGOT, SGPT, DB, TB and ALK) were analyzed in
he HCV infected patients (MAN, IRAN). Statistical analyses
erformed using t-test and Chi-square.
Results: We found that 27 cases (out of 60) were infected
y HCV but HBV-DNA was not seen in HCV infected patients.
ur ﬁndings also showed that none of samples were HBsAg
ositive but 9 (33%) (out of 27) HCV-RNA positive patients
ere anti-HBc positive and 11 (40.7%) were positive for
nti-HBs. We found that SGOT, SGPT, DB, TB and ALK are
bove normal in 27 (100%), 19 (70.3%), 12 (44.5%), 15 (55.5%)
nd 15 (55.5%) RNA-HCV positive patients, respectively. The
revalence of hepatitis C infection is very high in tha-
assemic patients and based on other studies our results
